{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:17:28Z","timestamp":1770751048534,"version":"3.50.0"},"publisher-location":"Basel","reference-count":128,"publisher":"Springer Basel","isbn-type":[{"value":"9783034808361","type":"print"},{"value":"9783034808378","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-3-0348-0837-8_1","type":"book-chapter","created":{"date-parts":[[2014,5,12]],"date-time":"2014-05-12T12:47:09Z","timestamp":1399898829000},"page":"1-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":198,"title":["The Role of Inflammation in Lung Cancer"],"prefix":"10.1007","author":[{"given":"M\u00f3nica","family":"Gomes","sequence":"first","affiliation":[]},{"given":"Ana Lu\u00edsa","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Coelho","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Ara\u00fajo","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Medeiros","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,5,13]]},"reference":[{"issue":"11","key":"1_CR1","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.bcp.2006.06.029","volume":"72","author":"BB Aggarwal","year":"2006","unstructured":"Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G (2006) Inflammation and cancer: how hot is the link? Biochem Pharmacol 72(11):1605\u20131621. doi:10.1016\/j.bcp.2006.06.029","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1158\/1078-0432.CCR-08-0149","volume":"15","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Vijayalekshmi RV, Sung B (2009) Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res 15(2):425\u2013430. doi:10.1158\/1078-0432.CCR-08-0149","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1634\/theoncologist.12-2-201","volume":"12","author":"A Araujo","year":"2007","unstructured":"Araujo A, Ribeiro R, Azevedo I, Coelho A, Soares M, Sousa B, Pinto D, Lopes C, Medeiros R, Scagliotti GV (2007) Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer\u2014A review of the literature. Oncologist 12(2):201\u2013210. doi:10.1634\/theoncologist.12-2-201","journal-title":"Oncologist"},{"issue":"1","key":"1_CR4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/1097-0142(20010101)91:1<113::AID-CNCR15>3.0.CO;2-7","volume":"91","author":"C Asselin-Paturel","year":"2001","unstructured":"Asselin-Paturel C, Megherat S, Vergnon I, Echchakir H, Dorothee G, Blesson S, Gay F, Mami-Chouaib F, Chouaib S (2001) Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction. Cancer 91(1):113\u2013122","journal-title":"Cancer"},{"issue":"1","key":"1_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1165\/rcmb.2002-0166TR","volume":"28","author":"JJ Atkinson","year":"2003","unstructured":"Atkinson JJ, Senior RM (2003) Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 28(1):12\u201324. doi:10.1165\/rcmb.2002-0166TR","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"12","key":"1_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.5306\/wjco.v2.i12.384","volume":"2","author":"A Azevedo","year":"2011","unstructured":"Azevedo A, Cunha V, Teixeira AL, Medeiros R (2011) IL-6\/IL-6R as a potential key signaling pathway in prostate cancer development. World J Clin Oncol 2(12):384\u2013396. doi:10.5306\/wjco.v2.i12.384","journal-title":"World J Clin Oncol"},{"issue":"36","key":"1_CR7","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.1200\/JCO.2009.23.5622","volume":"27","author":"CG Azzoli","year":"2009","unstructured":"Azzoli CG, Baker S Jr, Temin S, Pao W, Aliff T, Brahmer J, Johnson DH, Laskin JL, Masters G, Milton D, Nordquist L, Pfister DG, Piantadosi S, Schiller JH, Smith R, Smith TJ, Strawn JR, Trent D, Giaccone G (2009) American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol 27(36):6251\u20136266. doi:10.1200\/JCO.2009.23.5622","journal-title":"J Clin Oncol"},{"issue":"9255","key":"1_CR8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539\u2013545. doi:10.1016\/S0140-6736(00)04046-0","journal-title":"Lancet"},{"issue":"1","key":"1_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3816\/CLC.2003.n.021","volume":"5","author":"S Ballaz","year":"2003","unstructured":"Ballaz S, Mulshine JL (2003) The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer 5(1):46\u201362. doi:10.3816\/CLC.2003.n.021","journal-title":"Clin Lung Cancer"},{"issue":"5","key":"1_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1006\/cbir.2000.0647","volume":"25","author":"RR Baruch","year":"2001","unstructured":"Baruch RR, Melinscak H, Lo J, Liu Y, Yeung O, Hurta RA (2001) Altered matrix metalloproteinase expression associated with oncogene-mediated cellular transformation and metastasis formation. Cell Biol Int 25(5):411\u2013420. doi:10.1006\/cbir.2000.0647","journal-title":"Cell Biol Int"},{"issue":"1","key":"1_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcancer.2005.07.006","volume":"16","author":"A Ben-Baruch","year":"2006","unstructured":"Ben-Baruch A (2006) Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin Cancer Biol 16(1):38\u201352. doi:10.1016\/j.semcancer.2005.07.006","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"1_CR12","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1165\/ajrcmb.19.4.3247","volume":"19","author":"M Bihl","year":"1998","unstructured":"Bihl M, Tamm M, Nauck M, Wieland H, Perruchoud AP, Roth M (1998) Proliferation of human non-small-cell lung cancer cell lines: role of interleukin-6. Am J Respir Cell Mol Biol 19(4):606\u2013612. doi:10.1165\/ajrcmb.19.4.3247","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"1_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/sj.onc.1210662","volume":"27","author":"AC Borczuk","year":"2008","unstructured":"Borczuk AC, Papanikolaou N, Toonkel RL, Sole M, Gorenstein LA, Ginsburg ME, Sonett JR, Friedman RA, Powell CA (2008) Lung adenocarcinoma invasion in TGFbetaRII-deficient cells is mediated by CCL5\/RANTES. Oncogene 27(4):557\u2013564. doi:10.1038\/sj.onc.1210662","journal-title":"Oncogene"},{"issue":"3","key":"1_CR14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00000658-200203000-00017","volume":"235","author":"J Brabender","year":"2002","unstructured":"Brabender J, Park J, Metzger R, Schneider PM, Lord RV, Holscher AH, Danenberg KD, Danenberg PV (2002) Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer. Ann Surg 235(3):440\u2013443","journal-title":"Ann Surg"},{"issue":"4","key":"1_CR15","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/JTO.0b013e3182037b76","volume":"6","author":"RM Bremnes","year":"2011","unstructured":"Bremnes RM, Al-Shibli K, Donnem T, Sirera R, Al-Saad S, Andersen S, Stenvold H, Camps C, Busund LT (2011) The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer. J Thoracic Oncol: Official Pub Int Assoc Study Lung Cancer 6(4):824\u2013833. doi:10.1097\/JTO.0b013e3182037b76","journal-title":"J Thoracic Oncol: Official Pub Int Assoc Study Lung Cancer"},{"key":"1_CR001","doi-asserted-by":"publisher","unstructured":"Brody JS, Spira A (2006) State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc Am Thorc Soc 3(6):535\u2013537. doi:10.1513\/pats.200603-089MS","DOI":"10.1513\/pats.200603-089MS"},{"issue":"7","key":"1_CR16","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/jnci\/85.7.574","volume":"85","author":"PD Brown","year":"1993","unstructured":"Brown PD, Bloxidge RE, Stuart NS, Gatter KC, Carmichael J (1993) Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst 85(7):574\u2013578","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"1_CR17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1593\/neo.121758","volume":"15","author":"A Bruno","year":"2013","unstructured":"Bruno A, Focaccetti C, Pagani A, Imperatori AS, Spagnoletti M, Rotolo N, Cantelmo AR, Franzi F, Capella C, Ferlazzo G, Mortara L, Albini A, Noonan DM (2013) The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer. Neoplasia 15(2):133\u2013142","journal-title":"Neoplasia"},{"issue":"3","key":"1_CR18","doi-asserted-by":"publisher","first-page":"L438","DOI":"10.1152\/ajplung.00033.2005","volume":"289","author":"KT Chang","year":"2005","unstructured":"Chang KT, Huang CY, Tsai CM, Chiu CH, Lok YY (2005) Role of IL-6 in neuroendocrine differentiation and chemosensitivity of non-small cell lung cancer. Am J Physiol Lung Cell Mol Physiol 289(3):L438\u2013L445. doi:10.1152\/ajplung.00033.2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1_CR19","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2741\/3782","volume":"16","author":"W Chen","year":"2011","unstructured":"Chen W, Li Z, Bai L, Lin Y (2011) NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target. Front Biosci: J Virtual Libr 16:1172\u20131185","journal-title":"Front Biosci: J Virtual Libr"},{"issue":"6","key":"1_CR20","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00262-005-0062-1","volume":"55","author":"A Coelho","year":"2006","unstructured":"Coelho A, Calcada C, Catarino R, Pinto D, Fonseca G, Medeiros R (2006) CXCL12-3\u2019 A polymorphism and lung cancer metastases protection: new perspectives in immunotherapy? Cancer Immunol Immunother 55(6):639\u2013643. doi:10.1007\/s00262-005-0062-1","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"1_CR21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0012-1606(65)90005-9","volume":"12","author":"S Cohen","year":"1965","unstructured":"Cohen S (1965) The stimulation of epidermal proliferation by a specific protein (EGF). Dev Biol 12(3):394\u2013407","journal-title":"Dev Biol"},{"issue":"6917","key":"1_CR22","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860\u2013867. doi:10.1038\/nature01322","journal-title":"Nature"},{"issue":"5","key":"1_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","volume":"10","author":"J Cuzick","year":"2009","unstructured":"Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P, Jankowski J, La Vecchia C, Meyskens F, Senn HJ, Thun M (2009) Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 10(5):501\u2013507. doi:10.1016\/S1470-2045(09)70035-X","journal-title":"Lancet Oncol"},{"issue":"21","key":"1_CR24","doi-asserted-by":"publisher","first-page":"7674","DOI":"10.1158\/1078-0432.CCR-05-1205","volume":"11","author":"H Dalwadi","year":"2005","unstructured":"Dalwadi H, Krysan K, Heuze-Vourc\u2019h N, Dohadwala M, Elashoff D, Sharma S, Cacalano N, Lichtenstein A, Dubinett S (2005) Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer. Clin Cancer Res 11(21):7674\u20137682. doi:10.1158\/1078-0432.CCR-05-1205","journal-title":"Clin Cancer Res"},{"issue":"11","key":"1_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.5306\/wjco.v2.i11.367","volume":"2","author":"RA de Mello","year":"2011","unstructured":"de Mello RA, Marques DS, Medeiros R, Araujo AM (2011) Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies. World J Clin Oncol 2(11):367\u2013376. doi:10.5306\/wjco.v2.i11.367","journal-title":"World J Clin Oncol"},{"issue":"1","key":"1_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc1782","volume":"6","author":"KE de Visser","year":"2006","unstructured":"de Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6(1):24\u201337. doi:10.1038\/nrc1782","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1_CR27","first-page":"649","volume":"5","author":"F De Vita","year":"1998","unstructured":"De Vita F, Orditura M, Auriemma A, Infusino S, Roscigno A, Catalano G (1998) Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer. Oncol Rep 5(3):649\u2013652","journal-title":"Oncol Rep"},{"issue":"2","key":"1_CR28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1378\/chest.117.2.365","volume":"117","author":"F De Vita","year":"2000","unstructured":"De Vita F, Orditura M, Galizia G, Romano C, Roscigno A, Lieto E, Catalano G (2000) Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients. Chest 117(2):365\u2013373","journal-title":"Chest"},{"issue":"1","key":"1_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","volume":"25","author":"EI Deryugina","year":"2006","unstructured":"Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25(1):9\u201334. doi:10.1007\/s10555-006-7886-9","journal-title":"Cancer Metastasis Rev"},{"key":"1_CR30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000071371","volume":"37","author":"SM Dubinett","year":"2003","unstructured":"Dubinett SM, Sharma S, Huang M, Dohadwala M, Pold M, Mao JT (2003) Cyclooxygenase-2 in lung cancer. Prog Exp Tumor Res 37:138\u2013162","journal-title":"Prog Exp Tumor Res"},{"issue":"1","key":"1_CR31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00008390-199502000-00008","volume":"5","author":"W Dummer","year":"1995","unstructured":"Dummer W, Becker JC, Schwaaf A, Leverkus M, Moll T, Brocker EB (1995) Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma. Melanoma Res 5(1):67\u201368","journal-title":"Melanoma Res"},{"issue":"11","key":"1_CR32","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","volume":"3","author":"GP Dunn","year":"2002","unstructured":"Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3(11):991\u2013998. doi:10.1038\/ni1102-991","journal-title":"Nat Immunol"},{"issue":"5","key":"1_CR33","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/carcin\/18.5.1001","volume":"18","author":"C Duperron","year":"1997","unstructured":"Duperron C, Castonguay A (1997) Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A\/J mice. Carcinogenesis 18(5):1001\u20131006","journal-title":"Carcinogenesis"},{"issue":"3","key":"1_CR34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jlb.64.3.275","volume":"64","author":"KD Elgert","year":"1998","unstructured":"Elgert KD, Alleva DG, Mullins DW (1998) Tumor-induced immune dysfunction: the macrophage connection. J Leukoc Biol 64(3):275\u2013290","journal-title":"J Leukoc Biol"},{"issue":"4","key":"1_CR35","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","volume":"46","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46(4):765\u2013781. doi:10.1016\/j.ejca.2009.12.014","journal-title":"Eur J Cancer"},{"issue":"8","key":"1_CR36","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nri2808","volume":"10","author":"RA Flavell","year":"2010","unstructured":"Flavell RA, Sanjabi S, Wrzesinski SH, Licona-Limon P (2010) The polarization of immune cells in the tumour environment by TGFbeta. Nat Rev Immunol 10(8):554\u2013567. doi:10.1038\/nri2808","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"1_CR37","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1200\/JCO.2000.18.12.2354","volume":"18","author":"FV Fossella","year":"2000","unstructured":"Fossella FV, DeVore R, Kerr RN, Crawford J, Natale RR, Dunphy F, Kalman L, Miller V, Lee JS, Moore M, Gandara D, Karp D, Vokes E, Kris M, Kim Y, Gamza F, Hammershaimb L (2000) Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group. J Clin Oncol 18(12):2354\u20132362","journal-title":"J Clin Oncol"},{"key":"1_CR38","doi-asserted-by":"crossref","unstructured":"Gomes M, Coelho A, Ara\u00fajo A, Catarino R, Medeiros R (2011) 1137 POSTER Is MMP-9 Q279R a possible marker of prognostic in non small cell lung cancer? Eur J Cancer (Oxford 1990) 47:S134\u2013S135","DOI":"10.1016\/S0959-8049(11)70780-8"},{"issue":"1","key":"1_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.gene.2012.05.008","volume":"504","author":"M Gomes","year":"2012","unstructured":"Gomes M, Coelho A, Araujo A, Teixeira AL, Catarino R, Medeiros R (2012) Influence of functional genetic polymorphism (\u2212590C\/T) in non-small cell lung cancer (NSCLC) development: the paradoxal role of IL-4. Gene 504(1):111\u2013115. doi:10.1016\/j.gene.2012.05.008","journal-title":"Gene"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1471-2407-12-121","volume":"12","author":"P Gonzalez-Arriaga","year":"2012","unstructured":"Gonzalez-Arriaga P, Pascual T, Garcia-Alvarez A, Fernandez-Somoano A, Lopez-Cima MF, Tardon A (2012) Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival. BMC Cancer 12:121. doi:10.1186\/1471-2407-12-121","journal-title":"BMC Cancer"},{"issue":"7","key":"1_CR41","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1158\/0008-5472.CAN-10-2583","volume":"71","author":"AD Gregory","year":"2011","unstructured":"Gregory AD, Houghton AM (2011) Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res 71(7):2411\u20132416. doi:10.1158\/0008-5472.CAN-10-2583","journal-title":"Cancer Res"},{"issue":"1","key":"1_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/35094017","volume":"1","author":"RA Gupta","year":"2001","unstructured":"Gupta RA, Dubois RN (2001) Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1(1):11\u201321. doi:10.1038\/35094017","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1_CR43","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674. doi:10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"issue":"5","key":"1_CR44","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7150\/ijbs.3.328","volume":"3","author":"RE Harris","year":"2007","unstructured":"Harris RE, Beebe-Donk J, Alshafie GA (2007) Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study. Int J Biol Sci 3(5):328\u2013334","journal-title":"Int J Biol Sci"},{"issue":"7","key":"1_CR45","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1023\/A:1008375208574","volume":"11","author":"H Hatanaka","year":"2000","unstructured":"Hatanaka H, Abe Y, Kamiya T, Morino F, Nagata J, Tokunaga T, Oshika Y, Suemizu H, Kijima H, Tsuchida T, Yamazaki H, Inoue H, Nakamura M, Ueyama Y (2000) Clinical implications of interleukin (IL)-10 induced by non-small-cell lung cancer. Ann Oncol 11(7):815\u2013819","journal-title":"Ann Oncol"},{"issue":"9","key":"1_CR46","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1023\/A:1025774630993","volume":"20","author":"A Haynes","year":"2003","unstructured":"Haynes A, Shaik MS, Chatterjee A, Singh M (2003) Evaluation of an aerosolized selective COX-2 inhibitor as a potentiator of doxorubicin in a non-small-cell lung cancer cell line. Pharm Res 20(9):1485\u20131495","journal-title":"Pharm Res"},{"issue":"9202","key":"1_CR47","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0140-6736(00)82038-3","volume":"355","author":"PC Hoffman","year":"2000","unstructured":"Hoffman PC, Mauer AM, Vokes EE (2000) Lung cancer. Lancet 355(9202):479\u2013485. doi:10.1016\/S0140-6736(00)82038-3","journal-title":"Lancet"},{"issue":"15","key":"1_CR48","doi-asserted-by":"publisher","first-page":"5433","DOI":"10.1158\/1078-0432.CCR-05-0311","volume":"11","author":"Z Hu","year":"2005","unstructured":"Hu Z, Huo X, Lu D, Qian J, Zhou J, Chen Y, Xu L, Ma H, Zhu J, Wei Q, Shen H (2005) Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer. Clin Cancer Res 11(15):5433\u20135439. doi:10.1158\/1078-0432.CCR-05-0311","journal-title":"Clin Cancer Res"},{"key":"1_CR002","doi-asserted-by":"crossref","unstructured":"Ishihara K, Hirano T (2002) IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 13(4-5):357\u2013368","DOI":"10.1016\/S1359-6101(02)00027-8"},{"issue":"1","key":"1_CR49","first-page":"184","volume":"60","author":"M Jaiswal","year":"2000","unstructured":"Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ (2000) Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 60(1):184\u2013190","journal-title":"Cancer Res"},{"issue":"2","key":"1_CR50","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69\u201390. doi:10.3322\/caac.20107","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1_CR51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.rmed.2003.08.014","volume":"98","author":"C Jumper","year":"2004","unstructured":"Jumper C, Cobos E, Lox C (2004) Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment. Respir Med 98(2):173\u2013177","journal-title":"Respir Med"},{"issue":"7092","key":"1_CR52","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature04870","volume":"441","author":"M Karin","year":"2006","unstructured":"Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441(7092):431\u2013436. doi:10.1038\/nature04870","journal-title":"Nature"},{"issue":"3","key":"1_CR53","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/cr.2008.30","volume":"18","author":"M Karin","year":"2008","unstructured":"Karin M (2008) The IkappaB kinase\u2014a bridge between inflammation and cancer. Cell Res 18(3):334\u2013342. doi:10.1038\/cr.2008.30","journal-title":"Cell Res"},{"issue":"1","key":"1_CR54","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1):52\u201367. doi:10.1016\/j.cell.2010.03.015","journal-title":"Cell"},{"issue":"7","key":"1_CR55","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1158\/0008-5472.CAN-06-3941","volume":"67","author":"N Khan","year":"2007","unstructured":"Khan N, Afaq F, Kweon MH, Kim K, Mukhtar H (2007a) Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Cancer Res 67(7):3475\u20133482. doi:10.1158\/0008-5472.CAN-06-3941","journal-title":"Cancer Res"},{"issue":"1","key":"1_CR56","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/carcin\/bgl145","volume":"28","author":"N Khan","year":"2007","unstructured":"Khan N, Hadi N, Afaq F, Syed DN, Kweon MH, Mukhtar H (2007b) Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis 28(1):163\u2013173. doi:10.1093\/carcin\/bgl145","journal-title":"Carcinogenesis"},{"issue":"4","key":"1_CR57","first-page":"861","volume":"7","author":"FR Khuri","year":"2001","unstructured":"Khuri FR, Wu H, Lee JJ, Kemp BL, Lotan R, Lippman SM, Feng L, Hong WK, Xu XC (2001) Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res 7(4):861\u2013867","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1_CR58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/030089160609200211","volume":"92","author":"M Koc","year":"2006","unstructured":"Koc M, Ediger D, Budak F, Karadag M, Oral HB, Uzaslan E, Ege E, Gozu RO (2006) Matrix metalloproteinase-9 (MMP-9) elevated in serum but not in bronchial lavage fluid in patients with lung cancer. Tumori 92(2):149\u2013154","journal-title":"Tumori"},{"issue":"9","key":"1_CR59","first-page":"1982","volume":"53","author":"A Komori","year":"1993","unstructured":"Komori A, Yatsunami J, Suganuma M, Okabe S, Abe S, Sakai A, Sasaki K, Fujiki H (1993) Tumor necrosis factor acts as a tumor promoter in BALB\/3T3 cell transformation. Cancer Res 53(9):1982\u20131985","journal-title":"Cancer Res"},{"issue":"18","key":"1_CR60","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","volume":"363","author":"EL Kwak","year":"2010","unstructured":"Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, Maki RG, Ou SH, Dezube BJ, Janne PA, Costa DB, Varella-Garcia M, Kim WH, Lynch TJ, Fidias P, Stubbs H, Engelman JA, Sequist LV, Tan W, Gandhi L, Mino-Kenudson M, Wei GC, Shreeve SM, Ratain MJ, Settleman J, Christensen JG, Haber DA, Wilner K, Salgia R, Shapiro GI, Clark JW, Iafrate AJ (2010) Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 363(18):1693\u20131703. doi:10.1056\/NEJMoa1006448","journal-title":"N Engl J Med"},{"issue":"10","key":"1_CR61","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1182\/blood-2005-10-4160","volume":"107","author":"Q Lan","year":"2006","unstructured":"Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, Shen M, Berndt SI, Zahm SH, Holford TR, Leaderer B, Yeager M, Welch R, Boyle P, Zhang B, Zou K, Zhu Y, Chanock S (2006) Cytokine polymorphisms in the Th1\/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 107(10):4101\u20134108. doi:10.1182\/blood-2005-10-4160","journal-title":"Blood"},{"issue":"2","key":"1_CR62","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2217\/14796694.3.2.149","volume":"3","author":"JM Lee","year":"2007","unstructured":"Lee JM, Mao JT, Krysan K, Dubinett SM (2007) Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLC. Future Oncol 3(2):149\u2013153. doi:10.2217\/14796694.3.2.149","journal-title":"Future Oncol"},{"key":"1_CR63","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1756-9966-30-27","volume":"30","author":"F Li","year":"2011","unstructured":"Li F, Liu Y, Chen H, Liao D, Shen Y, Xu F, Wang J (2011) EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features. J Exp Clin Cancer Res 30:27. doi:10.1186\/1756-9966-30-27","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1_CR64","doi-asserted-by":"publisher","first-page":"e52093","DOI":"10.1371\/journal.pone.0052093","volume":"8","author":"Y Li","year":"2013","unstructured":"Li Y, Yang T, Wei S, Wang J, Wang M, Wang Y, Zhou Q, Liu H, Chen J (2013) Clinical significance of EML4-ALK fusion gene and association with EGFR and KRAS gene mutations in 208 Chinese patients with non-small cell lung cancer. PLoS One 8(1):e52093. doi:10.1371\/journal.pone.0052093","journal-title":"PLoS One"},{"issue":"11","key":"1_CR65","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1038\/sj.bjc.6601705","volume":"90","author":"EY Lin","year":"2004","unstructured":"Lin EY, Pollard JW (2004) Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer 90(11):2053\u20132058. doi:10.1038\/sj.bjc.6601705","journal-title":"Br J Cancer"},{"issue":"5","key":"1_CR66","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1172\/JCI31537","volume":"117","author":"WW Lin","year":"2007","unstructured":"Lin WW, Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117(5):1175\u20131183. doi:10.1172\/JCI31537","journal-title":"J Clin Invest"},{"issue":"10","key":"1_CR67","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/S1470-2045(08)70206-7","volume":"9","author":"H Linardou","year":"2008","unstructured":"Linardou H, Dahabreh IJ, Kanaloupiti D, Siannis F, Bafaloukos D, Kosmidis P, Papadimitriou CA, Murray S (2008) Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer. Lancet Oncol 9(10):962\u2013972. doi:10.1016\/S1470-2045(08)70206-7","journal-title":"Lancet Oncol"},{"issue":"2","key":"1_CR68","doi-asserted-by":"publisher","first-page":"e31251","DOI":"10.1371\/journal.pone.0031251","volume":"7","author":"D Liu","year":"2012","unstructured":"Liu D, Guo H, Li Y, Xu X, Yang K, Bai Y (2012) Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis. PLoS One 7(2):e31251. doi:10.1371\/journal.pone.0031251","journal-title":"PLoS One"},{"issue":"3","key":"1_CR69","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.lungcan.2007.07.005","volume":"58","author":"D Liu","year":"2007","unstructured":"Liu D, Nakano J, Ishikawa S, Yokomise H, Ueno M, Kadota K, Urushihara M, Huang CL (2007) Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer. Lung Cancer 58(3):384\u2013391. doi:10.1016\/j.lungcan.2007.07.005","journal-title":"Lung Cancer"},{"issue":"4","key":"1_CR70","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1158\/1541-7786.MCR-05-0261","volume":"4","author":"H Lu","year":"2006","unstructured":"Lu H, Ouyang W, Huang C (2006) Inflammation, a key event in cancer development. Molecular cancer research : MCR 4(4):221\u2013233. doi:10.1158\/1541-7786.MCR-05-0261","journal-title":"Molecular cancer research : MCR"},{"issue":"3","key":"1_CR71","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2004.08.012","volume":"6","author":"JL Luo","year":"2004","unstructured":"Luo JL, Maeda S, Hsu LC, Yagita H, Karin M (2004) Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 6(3):297\u2013305. doi:10.1016\/j.ccr.2004.08.012","journal-title":"Cancer Cell"},{"issue":"4","key":"1_CR72","doi-asserted-by":"publisher","first-page":"e10149","DOI":"10.1371\/journal.pone.0010149","volume":"5","author":"X Luo","year":"2010","unstructured":"Luo X, Ding Q, Wang M, Li Z, Mao K, Sun B, Pan Y, Wang Z, Zang YQ, Chen Y (2010) In vivo disruption of TGF-beta signaling by Smad7 in airway epithelium alleviates allergic asthma but aggravates lung carcinogenesis in mouse. PLoS One 5(4):e10149. doi:10.1371\/journal.pone.0010149","journal-title":"PLoS One"},{"issue":"7203","key":"1_CR73","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436\u2013444. doi:10.1038\/nature07205","journal-title":"Nature"},{"issue":"12","key":"1_CR74","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25(12):677\u2013686. doi:10.1016\/j.it.2004.09.015","journal-title":"Trends Immunol"},{"issue":"11","key":"1_CR75","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549\u2013555","journal-title":"Trends Immunol"},{"issue":"1","key":"1_CR76","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3816\/CLC.2005.n.019","volume":"7","author":"JT Mao","year":"2005","unstructured":"Mao JT, Cui X, Reckamp K, Liu M, Krysan K, Dalwadi H, Sharma S, Hazra S, Strieter R, Gardner B, Dubinett SM (2005) Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer. Clin Lung Cancer 7(1):30\u201339. doi:10.3816\/CLC.2005.n.019","journal-title":"Clin Lung Cancer"},{"issue":"7","key":"1_CR77","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1158\/1940-6207.CAPR-11-0078","volume":"4","author":"JT Mao","year":"2011","unstructured":"Mao JT, Roth MD, Fishbein MC, Aberle DR, Zhang ZF, Rao JY, Tashkin DP, Goodglick L, Holmes EC, Cameron RB, Dubinett SM, Elashoff R, Szabo E, Elashoff D (2011) Lung cancer chemoprevention with celecoxib in former smokers. Cancer Prev Res (Phila) 4(7):984\u2013993. doi:10.1158\/1940-6207.CAPR-11-0078","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5","key":"1_CR78","doi-asserted-by":"publisher","first-page":"L981","DOI":"10.1152\/ajplung.00239.2003","volume":"287","author":"CA Martey","year":"2004","unstructured":"Martey CA, Pollock SJ, Turner CK, O\u2019Reilly KM, Baglole CJ, Phipps RP, Sime PJ (2004) Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer. Am J Physiol Lung Cell Mol Physiol 287(5):L981\u2013L991. doi:10.1152\/ajplung.00239.2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"1_CR79","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1158\/1078-0432.CCR-09-0788","volume":"16","author":"DG Menter","year":"2010","unstructured":"Menter DG, Schilsky RL, DuBois RN (2010) Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward. Clin Cancer Res 16(5):1384\u20131390. doi:10.1158\/1078-0432.CCR-09-0788","journal-title":"Clin Cancer Res"},{"issue":"12","key":"1_CR80","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1038\/sj.bjc.6601814","volume":"90","author":"V Michalaki","year":"2004","unstructured":"Michalaki V, Syrigos K, Charles P, Waxman J (2004) Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer 90(12):2312\u20132316. doi:10.1038\/sj.bjc.6601814","journal-title":"Br J Cancer"},{"issue":"5","key":"1_CR81","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4065\/83.5.584","volume":"83","author":"JR Molina","year":"2008","unstructured":"Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (2008) Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc Mayo Clin 83(5):584\u2013594. doi:10.4065\/83.5.584","journal-title":"Mayo Clin Proc Mayo Clin"},{"issue":"4","key":"1_CR82","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1183\/09031936.00091707","volume":"30","author":"LM Montuenga","year":"2007","unstructured":"Montuenga LM, Pio R (2007) Tumour-associated macrophages in nonsmall cell lung cancer: the role of interleukin-10. Eur Respir J 30(4):608\u2013610. doi:10.1183\/09031936.00091707","journal-title":"Eur Respir J"},{"issue":"12","key":"1_CR83","first-page":"3803","volume":"8","author":"CJ Moran","year":"2002","unstructured":"Moran CJ, Arenberg DA, Huang CC, Giordano TJ, Thomas DG, Misek DE, Chen G, Iannettoni MD, Orringer MB, Hanash S, Beer DG (2002) RANTES expression is a predictor of survival in stage I lung adenocarcinoma. Clin Cancer Res 8(12):3803\u20133812","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1_CR84","first-page":"285","volume":"7","author":"Y Niwa","year":"2001","unstructured":"Niwa Y, Akamatsu H, Niwa H, Sumi H, Ozaki Y, Abe A (2001) Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res 7(2):285\u2013289","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1_CR85","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2217\/pgs.13.48","volume":"14","author":"A Nogueira","year":"2013","unstructured":"Nogueira A, Assis J, Catarino R, Medeiros R (2013) DNA repair and cytotoxic drugs: the potential role of RAD51 in clinical outcome of non-small-cell lung cancer patients. Pharmacogenomics 14(6):689\u2013700. doi:10.2217\/pgs.13.48","journal-title":"Pharmacogenomics"},{"issue":"12","key":"1_CR86","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1097\/JTO.0b013e3181f387e4","volume":"5","author":"DS O\u2019Callaghan","year":"2010","unstructured":"O\u2019Callaghan DS, O\u2019Donnell D, O\u2019Connell F, O\u2019Byrne KJ (2010) The role of inflammation in the pathogenesis of non-small cell lung cancer. J Thoracic Oncol: Off Pub Int Assoc Study Lung Cancer 5(12):2024\u20132036","journal-title":"J Thoracic Oncol: Off Pub Int Assoc Study Lung Cancer"},{"issue":"5574","key":"1_CR87","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1126\/science.1071420","volume":"296","author":"TP Padera","year":"2002","unstructured":"Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, Munn LL, Jain RK (2002) Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296(5574):1883\u20131886. doi:10.1126\/science.1071420","journal-title":"Science"},{"issue":"10","key":"1_CR88","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1586\/14737140.7.10.1405","volume":"7","author":"KA Peebles","year":"2007","unstructured":"Peebles KA, Lee JM, Mao JT, Hazra S, Reckamp KL, Krysan K, Dohadwala M, Heinrich EL, Walser TC, Cui X, Baratelli FE, Garon E, Sharma S, Dubinett SM (2007) Inflammation and lung carcinogenesis: applying findings in prevention and treatment. Expert Rev Anticancer Ther 7(10):1405\u20131421. doi:10.1586\/14737140.7.10.1405","journal-title":"Expert Rev Anticancer Ther"},{"issue":"5","key":"1_CR89","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/MEG.0b013e3283352cbb","volume":"22","author":"C Pereira","year":"2010","unstructured":"Pereira C, Pimentel-Nunes P, Brandao C, Moreira-Dias L, Medeiros R, Dinis-Ribeiro M (2010) COX-2 polymorphisms and colorectal cancer risk: a strategy for chemoprevention. Eur J Gastroenterol Hepatol 22(5):607\u2013613. doi:10.1097\/MEG.0b013e3283352cbb","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1_CR003","doi-asserted-by":"publisher","unstructured":"Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng YL, Bowman ED, Engels EA, Caporaso NE, Harris CC (2011) Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. J Nat Cancer Inst 103(14):1112\u20131122. doi:10.1093\/jnci\/djr216","DOI":"10.1093\/jnci\/djr216"},{"issue":"9","key":"1_CR90","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1158\/1535-7163.MCT-05-0082","volume":"4","author":"JS Rao","year":"2005","unstructured":"Rao JS, Gondi C, Chetty C, Chittivelu S, Joseph PA, Lakka SS (2005) Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. Mol Cancer Ther 4(9):1399\u20131408. doi:10.1158\/1535-7163.MCT-05-0082","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"1_CR91","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1556-0864(15)30035-6","volume":"2","author":"R Ribeiro","year":"2007","unstructured":"Ribeiro R, Araujo A, Lopes C, Medeiros R (2007) Immunoinflammatory mechanisms in lung cancer development: is leptin a mediator? J Thoracic Oncol: Off Pub Int Assoc Study Lung Cancer 2(2):105\u2013108","journal-title":"J Thoracic Oncol: Off Pub Int Assoc Study Lung Cancer"},{"issue":"23","key":"1_CR92","first-page":"5354","volume":"58","author":"N Rioux","year":"1998","unstructured":"Rioux N, Castonguay A (1998) Prevention of NNK-induced lung tumorigenesis in A\/J mice by acetylsalicylic acid and NS-398. Cancer Res 58(23):5354\u20135360","journal-title":"Cancer Res"},{"issue":"31","key":"1_CR93","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1200\/JCO.2009.23.5556","volume":"27","author":"R Roy","year":"2009","unstructured":"Roy R, Yang J, Moses MA (2009) Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 27(31):5287\u20135297. doi:10.1200\/JCO.2009.23.5556","journal-title":"J Clin Oncol"},{"issue":"2","key":"1_CR94","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/canjclin.56.2.69","volume":"56","author":"D Schottenfeld","year":"2006","unstructured":"Schottenfeld D, Beebe-Dimmer J (2006) Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 56(2):69\u201383","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"1_CR95","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.oraloncology.2008.02.012","volume":"44","author":"Z Serefoglou","year":"2008","unstructured":"Serefoglou Z, Yapijakis C, Nkenke E, Vairaktaris E (2008) Genetic association of cytokine DNA polymorphisms with head and neck cancer. Oral Oncol 44(12):1093\u20131099. doi:10.1016\/j.oraloncology.2008.02.012","journal-title":"Oral Oncol"},{"issue":"3","key":"1_CR96","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1734-1140(12)70857-5","volume":"64","author":"S Setia","year":"2012","unstructured":"Setia S, Sanyal SN (2012) Upregulation of intrinsic apoptotic pathway in NSAIDs mediated chemoprevention of experimental lung carcinogenesis. Pharmacol Rep: PR 64(3):615\u2013624","journal-title":"Pharmacol Rep: PR"},{"issue":"3","key":"1_CR97","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.lungcan.2005.07.007","volume":"50","author":"CM Shih","year":"2005","unstructured":"Shih CM, Lee YL, Chiou HL, Hsu WF, Chen WE, Chou MC, Lin LY (2005) The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer. Lung Cancer 50(3):291\u2013297. doi:10.1016\/j.lungcan.2005.07.007","journal-title":"Lung Cancer"},{"issue":"6","key":"1_CR98","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ejca.2006.01.003","volume":"42","author":"A Sica","year":"2006","unstructured":"Sica A, Schioppa T, Mantovani A, Allavena P (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42(6):717\u2013727. doi:10.1016\/j.ejca.2006.01.003","journal-title":"Eur J Cancer"},{"issue":"11","key":"1_CR99","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nrc1208","volume":"3","author":"PM Siegel","year":"2003","unstructured":"Siegel PM, Massague J (2003) Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 3(11):807\u2013821. doi:10.1038\/nrc1208","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1_CR100","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62(1):10\u201329. doi:10.3322\/caac.20138","journal-title":"CA Cancer J Clin"},{"key":"1_CR004","doi-asserted-by":"publisher","unstructured":"Smith CJ, Perfetti TA, King JA (2006) Perspectives on pulmonary inflammation and lung cancer risk in cigarette smokers. Inhalation Toxicol 18(9):667\u2013677. doi:10.1080\/08958370600742821","DOI":"10.1080\/08958370600742821"},{"key":"1_CR101","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.0105-2896.2004.00199.x","volume":"202","author":"MJ Smyth","year":"2004","unstructured":"Smyth MJ, Cretney E, Kershaw MH, Hayakawa Y (2004) Cytokines in cancer immunity and immunotherapy. Immunol Rev 202:275\u2013293. doi:10.1111\/j.0105-2896.2004.00199.x","journal-title":"Immunol Rev"},{"issue":"3","key":"1_CR102","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1525-1438.2003.13197.x","volume":"13","author":"R Srivani","year":"2003","unstructured":"Srivani R, Nagarajan B (2003) A prognostic insight on in vivo expression of interleukin-6 in uterine cervical cancer. Int J Gynecol Cancer: Off J Int Gynecol Cancer Soc 13(3):331\u2013339","journal-title":"Int J Gynecol Cancer: Off J Int Gynecol Cancer Soc"},{"issue":"16","key":"1_CR103","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1158\/1078-0432.CCR-10-2805","volume":"17","author":"K Suzuki","year":"2011","unstructured":"Suzuki K, Kachala SS, Kadota K, Shen R, Mo Q, Beer DG, Rusch VW, Travis WD, Adusumilli PS (2011) Prognostic immune markers in non-small cell lung cancer. Clin Cancer Res 17(16):5247\u20135256. doi:10.1158\/1078-0432.CCR-10-2805","journal-title":"Clin Cancer Res"},{"issue":"6C","key":"1_CR104","first-page":"4595","volume":"25","author":"U Takeshi","year":"2005","unstructured":"Takeshi U, Sadar MD, Suzuki H, Akakura K, Sakamoto S, Shimbo M, Suyama T, Imamoto T, Komiya A, Yukio N, Ichikawa T (2005) Interleukin-4 in patients with prostate cancer. Anticancer Res 25(6C):4595\u20134598","journal-title":"Anticancer Res"},{"key":"1_CR105","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fphar.2013.00015","volume":"4","author":"J Tang","year":"2013","unstructured":"Tang J, Salama R, Gadgeel SM, Sarkar FH, Ahmad A (2013) Erlotinib resistance in lung cancer: current progress and future perspectives. Front Pharmacol 4:15. doi:10.3389\/fphar.2013.00015","journal-title":"Front Pharmacol"},{"issue":"3","key":"1_CR106","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00432-010-0896-6","volume":"137","author":"AL Teixeira","year":"2011","unstructured":"Teixeira AL, Araujo A, Coelho A, Ribeiro R, Gomes M, Pereira C, Medeiros R (2011) Influence of TGFB1+869T>C functional polymorphism in non-small cell lung cancer (NSCLC) risk. J Cancer Res Clin Oncol 137(3):435\u2013439. doi:10.1007\/s00432-010-0896-6","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"1_CR107","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2(6):442\u2013454. doi:10.1038\/nrc822","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1_CR108","first-page":"275","volume":"52","author":"M Toi","year":"1992","unstructured":"Toi M, Bicknell R, Harris AL (1992) Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res 52(2):275\u2013279","journal-title":"Cancer Res"},{"issue":"9","key":"1_CR109","first-page":"513","volume":"15","author":"CC Tsai","year":"1999","unstructured":"Tsai CC, Chen CC, Lin CC, Chen CH, Lin TS, Shieh TY (1999) Interleukin-1 beta in oral submucous fibrosis, verrucous hyperplasia and squamous cell carcinoma tissues. Kaohsiung J Med Sci 15(9):513\u2013519","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"1_CR110","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1756-0500-6-139","volume":"6","author":"K Umekawa","year":"2013","unstructured":"Umekawa K, Kimura T, Kudoh S, Suzumura T, Oka T, Nagata M, Mitsuoka S, Matsuura K, Nakai T, Yoshimura N, Kira Y, Hirata K (2013) Plasma RANTES, IL-10, and IL-8 levels in non\u2013small-cell lung cancer patients treated with EGFR-TKIs. BMC Res Notes 6(1):139. doi:10.1186\/1756-0500-6-139","journal-title":"BMC Res Notes"},{"issue":"5","key":"1_CR111","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S1734-1140(11)70641-7","volume":"63","author":"V Vaish","year":"2011","unstructured":"Vaish V, Sanyal SN (2011) Chemopreventive effects of NSAIDs on cytokines and transcription factors during the early stages of colorectal cancer. Pharmacol Rep: PR 63(5):1210\u20131221","journal-title":"Pharmacol Rep: PR"},{"issue":"6\u20138","key":"1_CR112","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.imbio.2006.06.002","volume":"211","author":"JA Van Ginderachter","year":"2006","unstructured":"Van Ginderachter JA, Movahedi K, Hassanzadeh Ghassabeh G, Meerschaut S, Beschin A, Raes G, De Baetselier P (2006) Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology 211(6\u20138):487\u2013501. doi:10.1016\/j.imbio.2006.06.002","journal-title":"Immunobiology"},{"issue":"2","key":"1_CR113","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ijc.10329","volume":"99","author":"P Vihinen","year":"2002","unstructured":"Vihinen P, Kahari VM (2002) Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 99(2):157\u2013166. doi:10.1002\/ijc.10329","journal-title":"Int J Cancer"},{"issue":"24","key":"1_CR114","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.4161\/cc.9.24.14322","volume":"9","author":"HW Wang","year":"2010","unstructured":"Wang HW, Joyce JA (2010) Alternative activation of tumor-associated macrophages by IL-4: priming for protumoral functions. Cell Cycle 9(24):4824\u20134835","journal-title":"Cell Cycle"},{"issue":"7","key":"1_CR115","doi-asserted-by":"publisher","first-page":"e39525","DOI":"10.1371\/journal.pone.0039525","volume":"7","author":"YC Wang","year":"2012","unstructured":"Wang YC, Sung WW, Wu TC, Wang L, Chien WP, Cheng YW, Chen CY, Shieh SH, Lee H (2012) Interleukin-10 haplotype may predict survival and relapse in resected non-small cell lung cancer. PLoS One 7(7):e39525. doi:10.1371\/journal.pone.0039525","journal-title":"PLoS One"},{"issue":"9","key":"1_CR116","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrclinonc.2010.97","volume":"7","author":"DL Wheeler","year":"2010","unstructured":"Wheeler DL, Dunn EF, Harari PM (2010) Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nat Rev Clin Oncol 7(9):493\u2013507. doi:10.1038\/nrclinonc.2010.97","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"1_CR117","doi-asserted-by":"publisher","first-page":"11471","DOI":"10.3390\/ijms130911471","volume":"13","author":"K Wu","year":"2012","unstructured":"Wu K, House L, Liu W, Cho WC (2012) Personalized targeted therapy for lung cancer. Int J Mol Sci 13(9):11471\u201311496. doi:10.3390\/ijms130911471","journal-title":"Int J Mol Sci"},{"issue":"24","key":"1_CR118","doi-asserted-by":"publisher","first-page":"11565","DOI":"10.1158\/0008-5472.CAN-06-2540","volume":"66","author":"B Yan","year":"2006","unstructured":"Yan B, Wang H, Rabbani ZN, Zhao Y, Li W, Yuan Y, Li F, Dewhirst MW, Li CY (2006) Tumor necrosis factor-alpha is a potent endogenous mutagen that promotes cellular transformation. Cancer Res 66(24):11565\u201311570. doi:10.1158\/0008-5472.CAN-06-2540","journal-title":"Cancer Res"},{"issue":"5","key":"1_CR119","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/bjc.1995.212","volume":"71","author":"H Yanagawa","year":"1995","unstructured":"Yanagawa H, Sone S, Takahashi Y, Haku T, Yano S, Shinohara T, Ogura T (1995) Serum levels of interleukin 6 in patients with lung cancer. Br J Cancer 71(5):1095\u20131098","journal-title":"Br J Cancer"},{"issue":"27","key":"1_CR120","doi-asserted-by":"publisher","first-page":"10397","DOI":"10.1073\/pnas.0604008103","volume":"103","author":"H Yang","year":"2006","unstructured":"Yang H, Bocchetta M, Kroczynska B, Elmishad AG, Chen Y, Liu Z, Bubici C, Mossman BT, Pass HI, Testa JR, Franzoso G, Carbone M (2006) TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci USA 103(27):10397\u201310402. doi:10.1073\/pnas.0604008103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"1_CR121","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3748\/wjg.v13.i11.1747","volume":"13","author":"ZB Ye","year":"2007","unstructured":"Ye ZB, Ma T, Li H, Jin XL, Xu HM (2007) Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma. World J Gastroenterol 13(11):1747\u20131751","journal-title":"World J Gastroenterol"},{"issue":"4","key":"1_CR122","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1183\/09031936.00129306","volume":"30","author":"E Zeni","year":"2007","unstructured":"Zeni E, Mazzetti L, Miotto D, Lo Cascio N, Maestrelli P, Querzoli P, Pedriali M, De Rosa E, Fabbri LM, Mapp CE, Boschetto P (2007) Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer. Eur Respir J 30(4):627\u2013632. doi:10.1183\/09031936.00129306","journal-title":"Eur Respir J"},{"issue":"1","key":"1_CR123","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3978\/j.issn.2072-1439.2013.01.02","volume":"5","author":"P Zhan","year":"2013","unstructured":"Zhan P, Qian Q, Yu LK (2013) Prognostic value of COX-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis. J Thoracic Dis 5(1):40\u201347. doi:10.3978\/j.issn.2072-1439.2013.01.02","journal-title":"J Thoracic Dis"},{"issue":"3","key":"1_CR124","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ijc.2910520307","volume":"52","author":"S Zucker","year":"1992","unstructured":"Zucker S, Lysik RM, Malik M, Bauer BA, Caamano J, Klein-Szanto AJ (1992) Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: not an invariant correlation with metastasis. Int J Cancer 52(3):366\u2013371","journal-title":"Int J Cancer"}],"container-title":["Advances in Experimental Medicine and Biology","Inflammation and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-0348-0837-8_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T18:53:50Z","timestamp":1674154430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-0348-0837-8_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9783034808361","9783034808378"],"references-count":128,"URL":"https:\/\/doi.org\/10.1007\/978-3-0348-0837-8_1","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"13 May 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}